These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

81 related items for PubMed ID: 21964379

  • 1. Magnesium-deficiency does not alter calcineurin inhibitors activity in mice.
    Hulin A, Lamrani L, Sabbagh F, Tallet A, Lecerf F, Bac P, German-Fattal M.
    Transpl Immunol; 2012 Jan; 26(1):55-61. PubMed ID: 21964379
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Increased adherence after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation: a pre-experimental study.
    Doesch AO, Mueller S, Konstandin M, Celik S, Erbel C, Kristen A, Frankenstein L, Koch A, Dengler TJ, Ehlermann P, Zugck C, De Geest S, Katus HA.
    Transplant Proc; 2010 Dec; 42(10):4238-42. PubMed ID: 21168673
    [Abstract] [Full Text] [Related]

  • 9. Influence of early posttransplantation prednisone and calcineurin inhibitor dosages on the incidence of new-onset diabetes.
    Burroughs TE, Lentine KL, Takemoto SK, Swindle J, Machnicki G, Hardinger K, Brennan DC, Irish WD, Schnitzler MA.
    Clin J Am Soc Nephrol; 2007 May; 2(3):517-23. PubMed ID: 17699459
    [Abstract] [Full Text] [Related]

  • 10. The effects of calcineurin inhibitors on prostanoid synthesis: a randomized cross-over study in healthy humans.
    Øzbay LA, Stubbe J, Jespersen B, Jensen BL.
    Transpl Int; 2013 Feb; 26(2):131-7. PubMed ID: 23190385
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Advantageous effects of immunosuppression with tacrolimus in comparison with cyclosporine A regarding renal function in patients after heart transplantation.
    Helmschrott M, Rivinius R, Ruhparwar A, Schmack B, Erbel C, Gleissner CA, Akhavanpoor M, Frankenstein L, Ehlermann P, Bruckner T, Katus HA, Doesch AO.
    Drug Des Devel Ther; 2015 Feb; 9():1217-24. PubMed ID: 25759566
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Tacrolimus-associated hypomagnesemia in renal transplant recipients.
    Navaneethan SD, Sankarasubbaiyan S, Gross MD, Jeevanantham V, Monk RD.
    Transplant Proc; 2006 Jun; 38(5):1320-2. PubMed ID: 16797291
    [Abstract] [Full Text] [Related]

  • 18. Two-year experience with tacrolimus in renal transplantation after late conversion from cyclosporine therapy.
    Videla CO.
    Transplant Proc; 2009 Jun; 41(6):2659-63. PubMed ID: 19715995
    [Abstract] [Full Text] [Related]

  • 19. Calcineurin inhibitors and post-transplant weight gain.
    Ersoy A, Baran B, Ersoy C, Kahvecioglu S, Akdag I.
    Nephrology (Carlton); 2008 Oct; 13(5):433-9. PubMed ID: 18331443
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.